Publications
Publications
Show Results For
-
All HBS Web
(77)
- Faculty Publications (22)
Bribery
→
Page 1 of
22
Results
→
- March 2022 (Revised March 2024)
- Background Note
Legal Analysis: Bribery and Corruption
By: Nien-he Hsieh, Christopher Diak and Matthew Souba
- 2021
- Working Paper
The Political Economy of Anti-Bribery Enforcement
By: Lauren Cohen and Bo Li
This paper documents novel evidence on the influence of political incentives in the regulatory enforcement of foreign bribery. Using exogenous variation in the timing and geographic location of U.S. Congressional elections, we find that the probability of a Foreign...
View Details
- 2019
- Article
The Frequency of Corporate Misconduct: Public Enforcement versus Private Reality
By: Eugene F. Soltes
Perceptions about the frequency of misconduct—among the public, academics and even
regulators—have largely been formed by examining enforcement statistics, which rely on the detection and sanctioning of the misconduct. This study aims to illuminate the real occurrence...
View Details
- December 2018
- Teaching Note
An Innovative Anti-bribery Commitment?
By: Eugene Soltes
Teaching Note for HBS No. 119-039.
View Details
- Article
Business, Governments and Political Risk in South Asia and Latin America since 1970
By: G. Jones and Rachael Comunale
This article contributes to the literature on political risk in business and economic history by examining both new perspectives (risk encountered by companies domestically, rather than risk for foreign investors) and new settings (emerging markets economies in Latin...
View Details
- September 2018 (Revised November 2018)
- Case
An Innovative Anti-bribery Commitment?
By: Eugene Soltes
Reebonz, an online luxury goods platform based in Singapore that operates across the Asia-Pacific region, offers its investors the opportunity to redeem shares if either the firm or its founder are investigated by the U.S. or U.K governments with regard to complying...
View Details
- December 2017
- Case
Charity or Bribery?
By: Eugene Soltes and Brian Tilley
Filip Kowalski, a senior manager at the pharmaceutical company Healthgen, leads sales for the firm’s Polish division. While pitching Healthgen’s products, he develops a relationship with a director of a regional health fund who also runs a private foundation. After a...
View Details
- 2015
- Article
Approach, Ability, Aftermath: A Psychological Framework of Unethical Behavior at Work
By: C. Moore and F. Gino
Many of the scandalous organizational practices that have come to light in the last decade—rigging LIBOR, misselling payment protection insurance, rampant Wall Street insider trading, large-scale bribery of foreign officials, and the packaging and sale of toxic...
View Details
- March 2015
- Case
Statoil: Transparency on Payments to Governments
By: George Serafeim
The Statoil case describes the challenge of increasing transparency, in extractive industries, around host county government payments. The case describes Statoil's reasoning behind voluntarily disclosing host country government payments, and the events that led to this...
View Details
Keywords:
Corruption;
Disclosure;
Disclosure Strategy;
Regulation;
Industry Self-regulation;
Corporate Governance;
Corporate Accountability;
Bribery;
Sustainability;
Corporate Social Responsibility;
Government Legislation;
Cost vs Benefits;
Corporate Disclosure;
Mining;
Mining Industry;
United States
- November 2013
- Case
GlaxoSmithKline in China (A)
By: John A. Quelch and Margaret L. Rodriguez
Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to...
View Details
Keywords:
Public Health;
Pharmaceuticals;
China;
Bribery;
CSR;
Hong Bao;
Health Care;
Drug;
GlaxoSmithKline;
GSK;
Witty;
Government;
Marketing;
Health;
Health Care and Treatment;
Corporate Social Responsibility and Impact;
Corporate Strategy;
Corporate Governance;
Business and Government Relations;
Ethics;
Pharmaceutical Industry;
China;
United Kingdom;
United States
- November 2013 (Revised September 2015)
- Supplement
GlaxoSmithKline in China (B)
By: John A. Quelch and Margaret L. Rodriguez
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,...
View Details
Keywords:
Public Health;
Pharmaceuticals;
China;
Bribery;
CSR;
Hong Bao;
Health Care;
Drug;
GlaxoSmithKline;
GSK;
Witty;
Government;
Marketing;
Health;
Health Care and Treatment;
Corporate Social Responsibility and Impact;
Corporate Strategy;
Corporate Governance;
Business and Government Relations;
Ethics;
Pharmaceutical Industry;
China;
United Kingdom;
United States
- 2014
- Working Paper
Firm Competitiveness and Detection of Bribery
By: George Serafeim
Using survey data from firms around the world I analyze how detection of bribery has impacted a firm's competitiveness over the past year. Managers report that the most significant impact was on employee morale, followed by business relations, and then reputation and...
View Details
- September 2011
- Teaching Note
Caselets: Bribery and Extortion in International Business and Caselets (Abridged)(TN)
By: Louis T. Wells
Teaching Note for 700-055 and 707-052.
View Details
- July 2008 (Revised June 2012)
- Case
Corruption in Germany
By: Rawi E. Abdelal, Rafael Di Tella and Jonathan Schlefer
Why do managers become corrupt? Does corruption ever pay? When do friendly relations cross into bribery? How can CEOs manage and prevent outbreaks of corruption? These and other questions are raised by three short case studies of corruption in Germany: at the global...
View Details
- June 2007 (Revised September 2011)
- Case
Caselets: Bribery and Extortion in International Business (Abridged)
"Caselets" present several examples of decisions involving bribery or take other actions that could be considered as corrupt.
View Details
- July 2005 (Revised August 2006)
- Background Note
Bribery in Business: A Legal Perspective
By: Lynn S. Paine and Christopher Bruner
Provides a brief overview of the concept of bribery and the principal rationales prompting restrictions on such conduct. Also, reviews some of the most important U.S. and international laws prohibiting various forms of bribery.
View Details
- November 2001
- Background Note
Global Approaches to Anti-Corruption
By: Joseph Hinsey, Guhan Subramanian and Michelle Kalka
In the 1970s, a series of unpleasant revelations about corporate conduct, culminating in the public disclosure about unsavory business practices abroad by more than 400 U.S. corporations, jarred popular perceptions concerning business ethics. Congress responded by...
View Details
- October 2000 (Revised November 2000)
- Case
New Economy Ethics: YouKnowIt.com
By: Joseph L. Badaracco Jr. and Kim Slack
Entrepreneur Janice Schwartz is hoping to grow her start-up company by creating a technical advisory board and compensating members with discounted company stock. Schwartz is considering six candidates that can help her online education company in a variety of ways: as...
View Details
- September 1999 (Revised September 2011)
- Case
Caselets: Bribery and Extortion in International Business
"Caselets" present several examples of decisions involving bribery or take other actions that could be considered as corrupt.
View Details
- April 1999 (Revised August 2004)
- Case
Tarnished Rings? Olympic Games Sponsorship Issues
By: John A. Clendenin and Stephen A. Greyser
Focuses on the impacts for Olympic sponsor companies of the bribery allegations related to the Salt Lake City Olympic Committee's successful bid for the 2002 Winter Games. The spread of the scandal to the International Olympic Committee board members and the recent...
View Details